Breaking News, Promotions & Moves

Sanner Announces Management Changes

CEO Dr. Johannis Willem van Vliet will leave the company shortly as the company transitions to a CDMO.

By: Rachel Klemovitch

Assistant Editor

As part of Sanner’s strategic transformation into a Contract Development and Manufacturing Organization (CDMO) for medical devices and complex pharmaceutical drug delivery systems, the company announced a management change. CEO Dr. Johannis Willem van Vliet will leave the company shortly. Until the new CEO takes office in autumn 2025, Heino Lennartz will take over as interim CEO. As part of its strategic focus on the CDMO sector, the Sanner Group will now draw even more specifically on exp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters